Hemodialysis is a lifesaving but complex therapy. It hospitalization, and practice patterns in the DOPPS.
associated with hemodialysis is vital. The definition of
Patterns Study (DOPPS) provides a unique opportunity to review this problem and its determinants on a global level.
nonadherence and its assessment have both proven conMethods. Nonadherence was studied using data from the troversial [2, 3] . However, by compromising the delivery DOPPS, an international, observational, prospective hemoof dialysis, nonadherence can affect both patient morbiddialysis study. Patients were considered nonadherent if they ity and mortality, a finding that is well recognized [4] .
skipped one or more sessions per month, shortened one or It has been known for some time that survival of more sessions by more than 10 minutes per month, had a serum potassium level of Ͼ6.0 mEq/L, a serum phosphate level of ESRD patients is better in Europe and Japan in compari-Ͼ7.5 mg/dL (Ͼ2.4 mmol/L), or interdialytic weight gain (IDWG) son with the United States after adjustments for age, Ͼ5 .7% of body weight. Predictors of nonadherence were idengender, and diabetes mellitus [5] . Reasons for these diftified using logistic regression. Survival analysis used the Cox ferences are unclear. Differences in practice patterns proportional hazards model adjusting for case-mix.
Results. Skipping treatment was associated with increased may provide one explanation. A detailed examination mortality [relative risk (RR) ϭ 1.30, P ϭ 0.01], as were excesof practice patterns has been undertaken in the Dialysis sive IDWG (RR ϭ 1.12, P ϭ 0.047) and high phosphate levels
Outcomes and Practice Patterns Study (DOPPS), an (RR ϭ 1.17, P ϭ 0.001). Skipping also was associated with international, observational, prospective hemodialysis increased hospitalization (RR ϭ 1.13, P ϭ 0.04), as were high study initiated between 1996 and 1999 [6] . In addition phosphate levels (RR ϭ 1.07, P ϭ 0.05). Larger facility size (per 10 patients) was associated with higher odds ratios (OR) to practice patterns, patient behavior and adherence to of skipping (OR ϭ 1.03, P ϭ 0.06), shortening (OR ϭ 1.03, prescribed treatment may be other determinants of out-P ϭ 0.05), and IDWG (OR ϭ 1.02, P ϭ 0.07). An increased comes. A few studies have looked at the effect of nonadpercentage of highly trained staff hours was associated with herence on outcomes, but these have been based mainly lower OR of skipping (OR ϭ 0.84 per 10%, P ϭ 0.02); presence on patients from the United States, used a limited set of a dietitian was associated with lower OR of excessive IDWG (OR ϭ 0.75, P ϭ 0.08).
of variables, utilized relatively small sample sizes, and
Conclusion. Nonadherence was associated with increased
have not always measured the long-term consequences mortality risk (skipping treatment, excessive IDWG, and high of nonadherence. Two studies have shown that nonadphosphate) and with hospitalization risk (skipping, high phosherence to the hemodialysis regimen is associated with phate). Certain patient/facility characteristics also were associated with nonadherence.
an increased risk of death [7, 8] . One study has addressed international comparisons of nonadherence in hemodialysis with a descriptive approach [9] , based on question-
The present study was based on the hypothesis that facilities with lower nonadherence rates are likely to  2003 by the International Society of Nephrology manifest lower mortality and fewer hospitalizations. It information was obtained approximately every 4 months, was designed to provide an international perspective on including dates, diagnoses, and procedures associated the magnitude, distribution, and predictors of nonadherwith each hospitalization. ence (both at patient and facility level).
Measures of nonadherence
The patient measures of nonadherence used in this METHODS study are skipping one or more dialysis sessions in 1 Data source month, shortening one or more dialysis sessions by more The patient sample was drawn from the DOPPS datathan 10 minutes in 1 month, serum potassium concentrabase, which includes information about hemodialysis pation of Ͼ6.0 mEq/L, phosphate level of Ͼ7.5 mg/dL, or tients in Japan, the United States, and five European interdialytic weight gain (IDWG) Ͼ5.7% of body weight countries (France, Germany, Italy, Spain, and the United (the last cut-off was based on a Ͼ4 kg IDWG in a 70 Kingdom, collectively referred to as Euro-DOPPS). A kg patient). IDWG was obtained using the intradialytic nationally representative sample of dialysis facilities was weight loss, with the assumption that all the weight enrolled in each country, followed by selection of a random gained in the interdialytic interval was lost during the sample of hemodialysis patients at each participating dialysis session. These definitions are identical to those center. The study design and data collection instruments used in a prior publication from a USRDS special study were uniform across nations. Data on nonadherence [8] . A session missed because of hospitalization was not were collected at each dialysis facility by a center-based considered nonadherence. IDWG was estimated using research coordinator. Details of study design, facility the amount of weight removed during a hemodialysis sampling, patient sampling, and data collection have session and was expressed as the percentage of body been published previously [10] .
weight removed. The prevalence of each adherence mea-A data validation study was carried out in all five sure was calculated for the initial round of patients at European countries by the contracting research organitime of entry into the study. Skipping and shortening zation (CRO) in Europe. The CRO extracted data from status were evaluated for the 30 days prior to enrollment a sample of dialysis facilities, which was compared with into the DOPPS. IDWG was calculated from the most the data extracted by the staff at those facilities. While recent hemodialysis treatment before enrollment, and a formal data validation has not been conducted for potassium and phosphorus measurements were those obthe United States facilities, the values for age, diabetes tained on or before the enrollment date. mellitus as a primary cause of ESRD, and proportion of Practice pattern and mortality models included all pafemale and African American patients in the United tients enrolled and used data at the time of their entry States-DOPPS sample are very similar to the values reinto the study. ported for the 1997 United States population of in-center hemodialysis patients by the United States Renal Data Statistical analysis System (USRDS) [11] , suggesting that the United States-
The prevalence of each nonadherence measure was DOPPS data are indeed representative of the United calculated in each participating continent for the initial States ESRD population.
cross section of prevalent patients entering the study. The current study reflects data obtained from the To avoid the influence of residual renal function on urine United States (145 facilities, 3359 patients), Euro-DOPPS output and, hence, IDWG, patients who had been on (101 facilities, 2337 patients), and Japan (65 facilities, dialysis for less than 90 days were removed from the 1980 patients). An average of 30 adult chronic hemodialprevalence calculations, and adjustments were made in ysis patients (age Ͼ17 years) participated from each facilall models for patients who had been on hemodialysis ity. Study patients who departed from a facility were for less than 1 year. Linear mixed models were used to periodically replaced with patients who started hemodicompare the prevalence of each nonadherence measure alysis treatment at the facility. Data collection began in among the continents, taking into account facility clusterthe United States in June 1996, in Europe in May 1998, ing. The nonadherence measures of IDWG, potassium, and in Japan in February 1999. For the mortality analyand phosphate were adjusted for the day of the week of ses, patients were followed until January 2002 in the the blood draw. All patients were adjusted to a WednesUnited States, November 2000 in Europe, and October day blood draw value to ensure comparability. 2001 in Japan. Data were collected using a standardized Predictors of nonadherence were identified using lochart abstraction procedure performed by a facilitygistic regression. Model specification included age, race, based coordinator at each dialysis center. Data included ethnicity, gender, diabetic ESRD, depression (presence demographic characteristics and comorbid conditions. or absence of a diagnosis of depression in the past 12 For this analysis, data from an initial cross section of patients (i.e., prevalent patients) were used. Follow-up months was obtained from the DOPPS Medical Ques-tionnaire), facility size, years on dialysis, smoking, educaof 7676 patients used in the predictors of nonadherence analysis; the full sample was used for the mortality and tion, living status, marital status, employment, and prior failed transplantation. These models also took into acpractice pattern analyses. The demographic profile of the initial cross section of patients is given in Table 1 . count facility clustering. The results were expressed as adjusted odds ratios.
The proportion of African Americans was higher in the United States (33.5%) compared with Euro-DOPPS Cox proportional hazards models were used to express the strength of the relationship between each measure (1.6%) and Japan (0%). While the age groups were quite similar across nations, all comorbid conditions, except of nonadherence and both mortality and hospitalization. Mortality models examined time to death, while hospitalsmoking and other cardiac conditions, were more prevalent in the United States. Employment status for those ization models examined time to first hospitalization after enrollment into the study. Adjustments were made 18 to 60 years old was highest for Japan (51.1%) and lowest for the United States (13.7%); disability rates for the same variables used in the logistic regression analysis and were supplemented with 15 summary cowere lowest for Japan (4.9%) and higher for the United States (25.5%) and Euro-DOPPS (20.3%). The propormorbid conditions (diabetes, coronary heart disease, congestive heart failure, other cardiovascular diseases, tion of nursing home residents was highest for the United States (8.1%), and equivalent for Euro-DOPPS (2.3%) hypertension, cerebrovascular disease, peripheral vascular disease, lung disease, cancer, HIV/AIDS, gastrointesand Japan (2.6%). The percentage of married patients was highest for Japan (70.7%) versus 63.5% for Eurotinal bleed, neurologic disease, psychiatric disorder, cellulitis/gangrene, and dyspnea) and facility clustering effects.
DOPPS and 47.5% for the United States. Time on ESRD was longest for Japan (6.9 Ϯ 6.5 years). Cox models were stratified by continent. Facility clustering effects were addressed using robust standard estiDistribution of nonadherence measures mates based on the sandwich estimator [12] . A separate model was determined for each measure of nonadher- Table 2 shows the prevalence of each parameter of nonadherence studied. In the United States, 7.9% of ence, as was a model that included all five nonadherence measures. For measuring the association between hyperpatients skipped one or more hemodialysis sessions/ month compared with only 0.6% in Euro-DOPPS and phosphatemia and mortality, intact parathyroid hormone (PTH) levels were included in the model, as phosphate 0.6% in Japan. Similarly, more United States patients shortened a hemodialysis session by 10 minutes or more levels could, in part, reflect underlying hyperparathyroidism. The median follow-up time in each continent in a month (19.6%) compared with 9.8% in Euro-DOPPS and 5.7% in Japan. For patients with excessive was as follows: Euro-DOPPS ϭ 1.8 years, Japan ϭ 2.0 years, and the United States ϭ 2.9 years.
IDWG, the distribution was highest in Japan (34.5%) compared with 16.8% in the United States and 11.0% Logistic regression also was employed to investigate the relationship between facility practice patterns and in Euro-DOPPS. Hyperphosphatemia Ն7.5g/dL was present among 15.4% of patients in the United States, patient nonadherence. Practice patterns investigated included facility size, percentage of highly trained staff 12.8% in Euro-DOPPS, and 12.1% in Japan. Finally, hyperkalemia of Ͼ6.0 mEq/L was seen more commonly hours in relation to direct patient care staff hours, percentage of highly trained staff (defined as having 2 or in Euro-DOPPS (20.0%) than in Japan (7.6%) or the United States (6.3%). more years of formal nursing training), presence of a dietitian in the unit, and physician/patient contact time Patient level predictors of nonadherence (minutes/month). These models were adjusted for the list of comorbid conditions previously described, as well Table 3 shows the results from logistic regression analyses of possible predictors of the presence of nonadheras for the predictors of nonadherence variables and continent of residence. Models took into account facility ence among the hemodialysis populations studied. Analyses adjusted for all factors in this table, as well as for clustering. All analyses were carried out using SAS version 8.2 [13] . A P value of Ͻ0.05 was considered to those in Table 1 nonadherence (Table 4) . For any given measure of nonCorrelates of nonadherence with mortality adherence, the odds of any other measure of nonadher- Table 5 shows the relative risk (RR) of mortality for ence were greater than 1.0 and the majority of these each of the five measures of nonadherence for all DOPPS odds ratios (OR) were statistically significant. The highcountries. Skipping one or more dialysis sessions a month est correlation was seen between shortening and skipping (versus not skipping) was associated with a relative mortality risk of 1.30 (P ϭ 0.01). The relative mortality risks hemodialysis sessions (OR ϭ 4.91; P Ͻ 0.05). for excessive IDWG and for phosphate levels Ͼ7.5 P ϭ 0.14) and hyperkalemia (RR ϭ 1.09; P ϭ 0.14) were not statistically significant. The measures of nonadhermg/dL were 1.12 (P ϭ 0.05) and 1.17 (P ϭ 0.001), respectively. The RR for the association between mortality ence were independently associated with higher mortality. The presence of comorbid conditions showed a and hyperphosphatemia increased to 1.27 (P ϭ 0.0001) following adjustment for intact PTH levels. The RR assosignificant increase in mortality, as did lower dialysis dose. ciated with shortening dialysis treatments (RR ϭ 1.11; perspective. Quantification of the degree of nonadherence is clearly required to understand the impact of treatment on a patient's life. But solutions to this problem are difficult, and multiple aspects of therapy have to be Correlates of nonadherence with hospitalization addressed [4] . However, consensus does not exist as to Table 5 also shows the RR for hospitalization (mod- what these ought to be. The National Kidney Foundaeled as time to first hospitalization after entering the tion/Kidney Disease Outcomes Quality Initiative Clinistudy) for each of the five measures of nonadherence cal Practice Guidelines pertaining to patient adherence for all DOPPS countries. Skipping one or more dialysis rightly emphasize compliance with hemodialysis itself sessions a month (versus not skipping) was associated but do not address other aspects of patient nonadherence with a RR of 1.13 (P ϭ 0.04) for hospitalization. For [14] . While no gold standard exists, the sensitivity and phosphate levels Ͼ7.5 mg/dL the RR was 1. 
practice patterns
They concluded that nonadherence (based on "missed Dialysis facility size and certain facility practice patdialysis" treatments as the main outcome measure) was terns were found to be significantly associated with nonmuch more common in the United States compared with adherence measures (Table 6 ). Larger facility size (per Sweden and Japan and recommended further study to de-10 more hemodialysis patients) was associated with an termine the significance of their results for patient survival. increased likelihood of skipping (OR ϭ 1.03, P ϭ 0.06),
In this study of representative samples of hemodialysis shortening (OR ϭ 1.03, P ϭ 0.05), and IDWG (OR ϭ patients from seven countries, measurable indices of 1.02, P ϭ 0.07). When looking for an optimum facility nonadherence that have been published previously [8] size, it was found that the risk of skipping significantly were related to patient outcomes. Behavioral compliance increased at a facility size of Ͼ60 patients (OR ϭ 1.77, measures of skipping dialysis and shortening dialysis P ϭ 0.001; reference group facility size Ͻ60 patients).
times were studied, as well as indirect measures of dietary The odds of shortening sessions increased significantly and medication compliance such as IDWG, serum phosin facilities with more than 75 patients (OR ϭ 1.57, P ϭ phate levels, and serum potassium levels. By adjusting 0.006; reference group facility size Ͻ75 patients), while for patients who had been on dialysis for less than 1 the odds for excessive IDWG went up significantly at a year, an attempt was made in this study to account for facility size of 125 patients or more (OR ϭ 1.45, P ϭ the confounding influence of residual renal function on 0.03; reference group facility size Ͻ125 patients). For a IDWG. To account for the possibility of survival bias 10% increase in highly trained staff hours, there was a that could potentially influence results in an analysis of decrease in the likelihood of skipping (OR ϭ 0.84, P ϭ a cross section of prevalent patients, all analyses were 0.02). Odds of skipping were 11% lower for every 10% adjusted for multiple covariates, including years on heincrease in highly trained staff in the unit (OR ϭ 0.89, modialysis. It also was thought desirable to express P ϭ 0.06). The presence of a dietitian in the facility was IDWG as a percentage of body weight, because absolute associated with a lower likelihood of nonadherence in values can have different implications for individuals of different weight. Furthermore, for the purposes of this terms of IDWG (OR ϭ 0.75, P ϭ 0.08), while a positive study, intradialytic weight loss served as a proxy for [8, 19] , although this remains a controversial subject [20] . IDWG since data on weights determined for two consec-
The magnitude of mortality risk associated with skipping utive sessions were not uniformly available. Phosphate dialysis seems almost as large as that predicted from the levels above 7.5 mg/dL were more likely to reflect nonaddose effect alone (with Kt/V in the model, the RR for herence with diet and/or medication than levels between mortality was 1.28, P ϭ 0.05). This suggests that the 5.5 mg/dL and 6.5 mg/dL. These latter levels could exist detrimental effect of skipping on mortality risk is indedespite a patient's attempt at adherence with diet and pendent of the delivered dialysis dose and that other drugs [15, 16] , the result of the relatively inefficient phosdetrimental factors or behaviors associated with skipping phate clearance achieved by conventional three times a dialysis may contribute to the mortality risk. Hyperphosweek hemodialysis [17] .
phatemia was significantly associated with a higher RR Analysis revealed significant correlations between difof mortality, confirming previous reports [21] . It is recogferent measures of nonadherence. Results in this regard nized that hyperphosphatemia may not simply reflect are in agreement with the study by Leggat et al [8] but nonadherence with regard to diet. It may also be secondat variance with Kimmel et al [18] . In the latter study, ary to hyperparathyroidism, as well as underdialysis. at three urban hemodialysis centers in the United States When the mortality analyses were adjusted for intact with predominantly African American populations, no PTH levels, the association between hyperphosphatemia correlation was observed between skipping and shortenand mortality seemed to strengthen. Hyperkalemia above ing behavior. The authors reasoned that this possibly 6.0 mEq/L failed to achieve statistical significance with reflected different underlying behavioral causes for skiprespect to RR of mortality. The latter finding, however, ping versus shortening.
should not lull practicing nephrologists into ignoring Multiple demographic characteristics were observed marked hyperkalemia as a risk factor for mortality in an in this study to predict patient nonadherence (Table 3) .
individual patient and may indicate that the criterion of Younger age, African American race, female gender, hyperkalemia is not always indicative of nonadherence disabled status, living alone, smoking, depression, and and may be dependent upon variations in dietary pattern. time on ESRD were associated with higher odds of nonFew studies have looked at the effect of nonadherence adherence with one or more of the measurements of on mortality. Held et al [7] reported a 14% higher risk nonadherence. Some college education and prior kidney of death from a single skipped session in one month. transplant were associated with neutral odds of nonadIfudu, Henry, and Friedman [22], however, reported no herence in all the domains studied. Living in a nursing increased risk. Leggat et al [8] , based on a USRDS spehome was associated with 47% lower odds of skipping cial study, reported definite mortality associations with treatment, perhaps owing to staff supervision and prenonadherence with respect to skipping or shortening sesdictable transportation arrangements to and from the sions. Based on their analysis, one or more skipped hedialysis unit. A number of patient comorbidities tested modialysis session per month was associated with a 25% were not significantly associated with nonadherence.
higher risk of death (P Ͻ 0.01). Shortening three or more Skipping and shortening hemodialysis treatments is sessions, excessive IDWG, and hyperphosphatemia also much more common in the United States than in Eurocorrelate with heightened mortality risk, as in this study. DOPPS or Japan. Excessive IDWG was more prevalent Greater IDWG is associated with better nutritional indiin Japan, followed by the United States and Euroces and lower mortality in a Japanese hemodialysis regis-DOPPS. High phosphate was almost equally prevalent try report [23] , as well as in a single-center study by in each of the three geographic regions, and potassium Testa and Beaud [24] . However, these results support the levels of Ͼ6.0 mEq/L were more prevalent in Eurocontention that, after adjustments for age, race, gender, DOPPS compared with Japan and the United States.
ethnicity, time on ESRD, 15 summary comorbid condiFurthermore, while skipping one or more dialysis sestions, depression, smoking status, education, employsions in a month was associated with a 30% increased ment, and living status, high IDWG is associated with a mortality risk compared with not skipping, shortening higher mortality risk. It is conceivable that the "J-shaped" dialysis time was associated with an 11% higher RR of relationship suggested in the literature [23, 24] is not mortality than not shortening. Whereas the latter failed seen because of adjustments made in this study for the to reach statistical significance, the effect was in the exvariables that would possibly be correlated with low pected direction and likely to be of clinical relevance, IDWG (e.g., age, nursing home residence, depression, as shortening dialysis time represents a behavioral tenand comorbidity). The high mortality risk is perhaps dency to other measures of nonadherence in such pasecondary to excessive cardiovascular burden related to tients. Skipping dialysis decreases the total delivered expanded extracellular volume. It has been reasoned dose and may affect mortality by that mechanism. Dose quite convincingly that excessive salt intake increases of dialysis previously has been shown to have a relationship with RR of mortality in large observational studies thirst, and patients should be counseled to restrict salt intake in the first instance so as to significantly reduce CONCLUSION their water intake [25] . This is the first comprehensive international report The data pertaining to hospitalization as an outcome on nonadherence in hemodialysis. Measures described of nonadherence (Table 5) indicate that skipping dialysis include prevalence, patient and facility-level predictors, is a significant risk factor for hospitalization (with a 16% and hospitalization and mortality associations. Nonadherence, as measured by skipping and shortening hemohigher risk of hospitalization in those who skipped one dialysis treatments, was more prevalent in the United or more sessions of hemodialysis in a month versus those
States than in Euro-DOPPS and Japan. Japan demonwho did not skip). The risk of hospitalization was 7% strated the highest prevalence of IDWG per dry weight. higher in those with a phosphate level Ͼ7.5 mg/dL. These After adjustments for multiple covariates, increased results are consistent with the mortality data. Previous mortality risk was associated with skipping and shortenstudies have not looked at hospitalization as an outcome ing dialysis sessions, high IDWG, and hyperphosphatewhile evaluating nonadherence, despite its importance mia. Risk of hospitalization was significantly higher for with regard to patient morbidity and its effect on cost those patients who skipped dialysis sessions and ran high of care.
phosphate levels, with implications for patient morbidity Facility size was correlated by group to see if this was and thus cost to health care systems. Larger facilities a consistent linear pattern. As shown in Table 6 , smaller were more likely to encounter a higher level of nonadfacilities (lowest quartile) were associated with the obherence, especially with respect to skipping and shortenservation on skipping, while the larger facilities (highest ing dialysis. Highly trained staff may help to decrease quartile) were associated with IDWG. Thus, facilities nonadherence. The presence of a dietitian in the facility with more than 60 patients had a significantly higher OR was found to lower the odds of excessive IDWG. Approof skipping dialysis (1.77, P ϭ 0.001) and those with priate measures to minimize the nonadherence among more than 75 patients had a significantly higher OR of patients (both at the patient and facility levels) are likely to reduce mortality and hospitalization risks in hemodialshortening dialysis (1.57, P ϭ 0.006). It was only when ysis patients. Further research into effective ways to minfacility size exceeded 125 patients that a significantly imize nonadherence rates must continue in order to imhigher OR was detected for IDWG. This analysis, the prove outcomes among hemodialysis patients. authors believe, is the first to report a relationship between facility size and measures of patient nonadher-ACKNOWLEDGMENT ence. A prior national study on facility size and intermeThis study was funded by an unrestricted grant from Kirin-Amgen. diate patient outcomes did not have information on nonadherence in the hemodialysis patients studied and 
